View the Show Notes Page for This Episode
Become a Member to Receive Exclusive Content
Sign Up to Receive Peter’s Weekly Newsletter
This special episode is a rebroadcast of AMA #30, now made available to everyone, in which Peter and Bob Kaplan dive deep into all things related to studying studies to help one sift through the noise to find the signal. They define various types of studies, how a study progresses from idea to execution, and how to identify study strengths and limitations. They explain how clinical trials work, as well as biases and common pitfalls to watch out for. They dig into key factors that contribute to the rigor (or lack thereof) of an experiment, and they discuss how to measure effect size, differentiate relative risk from absolute risk, and what it really means when a study is statistically significant. Finally, Peter lays out his personal process when reading through scientific papers.
We discuss:
Connect With Peter on Twitter, Instagram, Facebook and YouTube
#137 - Paul Offit, M.D.: An expert perspective on COVID-19 vaccines
#136 - AMA #17: Body composition methods tour de force, insulin resistance, and Topo Chico
#135 - BJ Miller, M.D.: How understanding death leads to a better life
#134 - James O’Keefe, M.D.: Preventing cardiovascular disease and the risk of too much exercise.
#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy
#132 - AMA #16: Exploring hot and cold therapy
#131 - Beth Lewis: The Art of Stability: Learning about pain, mitigating injury, and moving better through life
#130 - Carol Tavris, Ph.D. & Elliot Aronson, Ph.D.: Recognizing and overcoming cognitive dissonance
#129 - Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology
#128 – Irene Davis, Ph.D.: The evolution of the foot, running injuries, and minimalist shoes
#127 - AMA #3 with sleep expert, Matthew Walker, Ph.D.: Fasting, gut health, blue light, caffeine, REM sleep, and more
#126 – Matthew Walker, Ph.D.: Sleep and immune function, chronotypes, hygiene tips, and addressing questions about his book
#125 - John Arnold: The most prolific philanthropist you may not have heard of
#124 - AMA #15: Real-world case studies—metabolic dysregulation, low testosterone, menopause, and more
#123 - Joan Mannick, M.D. & Nir Barzilai, M.D.: Rapamycin and metformin—longevity, immune enhancement, and COVID-19
#122 - Lori Gottlieb: Understanding pain, therapeutic breakthroughs, and keys to enduring emotional health
#121 - Azra Raza, M.D.: Why we're losing the war on cancer
#120 - AMA with Dom D’Agostino, Ph.D., Part II of II: Ketosis for cancer and chronic disease, hyperbaric oxygen therapy, and the effect of ketosis on female health
#119 - Terry Real: Breaking the cycle of shame, anger, and depression
#118 - Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Huberman Lab
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.